TickerFacts.

Viridian Therapeutics, Inc. (VRDN): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Weighted Average Diluted Shares is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

44.76M
Year ended 2023-12-31
+132.6%
3-year compound annual growth
2020-12-31: 3.56M2021-12-31: 11.92M2022-12-31: 32.09M2023-12-31: 44.76M44.76M
2020-12-31 Weighted Average Diluted Shares (shares) 2023-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2023-12-3144.76M+39.5%2024-02-27, From 2023-01-01
2022-12-3132.09M+169.2%2024-02-27, From 2022-01-01
2021-12-3111.92M+235.1%2024-02-27, From 2021-01-01
2020-12-313.56Mn/a2022-03-11, From 2020-01-01